Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak
| Errataetall: |
CommentOn: J Infect. 2020 Sep;81(3):420-426. - PMID 32504745 |
|---|---|
| Media Type: |
Electronic Article |
| Year of Publication: |
2021 |
|---|
| Contained In: |
The Journal of infection - Vol. 82, No. 1 (2021), p. 159-198 |
|---|
| Language: |
English |
|---|
| Contributors: |
Blairon, Laurent |
|---|
| Links: |
|---|
| Keywords: |
COVID-19 |
|---|
| Notes: |
Date Revised 26.01.2021 published: Print-Electronic CommentOn: J Infect. 2020 Sep;81(3):420-426. - PMID 32504745 Citation Status In-Process Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine |
|---|
| Physical Description: |
Online-Ressource |
|---|
| doi: |
10.1016/j.jinf.2020.07.033 |
|---|---|
| PMID: |
32739485 |
| PPN (Catalogue-ID): |
NLM314076425 |
|---|
| LEADER | 01903nma a2200577 c 4500 | ||
|---|---|---|---|
| 001 | NLM314076425 | ||
| 003 | DE-601 | ||
| 005 | 20210126213659.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200803s2021 000 0 eng d | ||
| 024 | 7 | |a 10.1016/j.jinf.2020.07.033 |2 doi | |
| 028 | 5 | 2 | |a pubmed21n1123.xml |
| 035 | |a S0163-4453(20)30514-4 | ||
| 035 | |a (DE-599)NLM32739485 | ||
| 040 | |b ger |c GBVCP | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Blairon, Laurent | |
| 245 | 1 | 0 | |a Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak |h Elektronische Ressource |
| 300 | |a Online-Ressource | ||
| 500 | |a Date Revised 26.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: J Infect. 2020 Sep;81(3):420-426. - PMID 32504745 | ||
| 500 | |a Citation Status In-Process | ||
| 500 | |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine | ||
| 611 | 2 | 7 | |a Letter |2 gnd |
| 611 | 2 | 7 | |a Comment |2 gnd |
| 655 | 7 | |a COVID-19 |2 gnd | |
| 655 | 7 | |a Healthcare workers |2 gnd | |
| 655 | 7 | |a SARS-CoV-2 |2 gnd | |
| 655 | 7 | |a Screening |2 gnd | |
| 655 | 7 | |a Seroprevalence |2 gnd | |
| 689 | 0 | 0 | |A f |a Letter |
| 689 | 0 | 1 | |A f |a Comment |
| 689 | 0 | |5 DE-601 | |
| 689 | 1 | 0 | |a COVID-19 |
| 689 | 1 | 1 | |a Healthcare workers |
| 689 | 1 | 2 | |a SARS-CoV-2 |
| 689 | 1 | 3 | |a Screening |
| 689 | 1 | 4 | |a Seroprevalence |
| 689 | 1 | |5 DE-601 | |
| 700 | 1 | |a Mokrane, Saphia | |
| 700 | 1 | |a Wilmet, Alain | |
| 700 | 1 | |a Dessilly, Géraldine | |
| 700 | 1 | |a Kabamba-Mukadi, Benoît | |
| 700 | 1 | |a Beukinga, Ingrid | |
| 700 | 1 | |a Tré-Hardy, Marie | |
| 773 | 0 | 8 | |i in |t The Journal of infection |g Vol. 82, No. 1 (2021), p. 159-198 |q 82:1<159-198 |w (DE-601)NLM012791911 |x 1532-2742 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.jinf.2020.07.033 |3 Volltext |
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 82 |j 2021 |e 1 |b 21 |c 01 |h 159-198 | ||